235 related articles for article (PubMed ID: 31187136)
1. YAP mediates the positive regulation of hnRNPK on the lung adenocarcinoma H1299 cell growth.
Xu L; Zhang T; Huang W; Liu X; Lu J; Gao X; Zhang YF; Liu L
Acta Biochim Biophys Sin (Shanghai); 2019 Jul; 51(7):677-687. PubMed ID: 31187136
[TBL] [Abstract][Full Text] [Related]
2. Regulation and related mechanism of GSN mRNA level by hnRNPK in lung adenocarcinoma cells.
Liu XH; Ma J; Feng JX; Feng Y; Zhang YF; Liu LX
Biol Chem; 2019 Jun; 400(7):951-963. PubMed ID: 30771276
[TBL] [Abstract][Full Text] [Related]
3. ANKHD1 promotes proliferation and invasion of non‑small‑cell lung cancer cells via regulating YAP oncoprotein expression and inactivating the Hippo pathway.
Liu XF; Han Q; Rong XZ; Yang M; Han YC; Yu JH; Lin XY
Int J Oncol; 2020 May; 56(5):1175-1185. PubMed ID: 32319569
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneous nuclear ribonucleoprotein K promotes the progression of lung cancer by inhibiting the p53-dependent signaling pathway.
Li M; Yang X; Zhang G; Wang L; Zhu Z; Zhang W; Huang H; Gao R
Thorac Cancer; 2022 May; 13(9):1311-1321. PubMed ID: 35352475
[TBL] [Abstract][Full Text] [Related]
5. m
Wu J; Yi T; Zhuo C; Wang D; Zhang M; Hu R; Wu D; Hou G; Xing Y
J Cell Physiol; 2024 May; 239(5):e31220. PubMed ID: 38372068
[TBL] [Abstract][Full Text] [Related]
6. A TNFR2-hnRNPK Axis Promotes Primary Liver Cancer Development via Activation of YAP Signaling in Hepatic Progenitor Cells.
Meng Y; Zhao Q; An L; Jiao S; Li R; Sang Y; Liao J; Nie P; Wen F; Ju J; Zhou Z; Wei L
Cancer Res; 2021 Jun; 81(11):3036-3050. PubMed ID: 33619115
[TBL] [Abstract][Full Text] [Related]
7. MiR-4319 hinders YAP expression to restrain non-small cell lung cancer growth through regulation of LIN28-mediated RFX5 stability.
Yang Y; Li H; Liu Y; Chi C; Ni J; Lin X
Biomed Pharmacother; 2019 Jul; 115():108956. PubMed ID: 31096145
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of ERK1/2 down-regulates the Hippo/YAP signaling pathway in human NSCLC cells.
You B; Yang YL; Xu Z; Dai Y; Liu S; Mao JH; Tetsu O; Li H; Jablons DM; You L
Oncotarget; 2015 Feb; 6(6):4357-68. PubMed ID: 25738359
[TBL] [Abstract][Full Text] [Related]
9. Fascin 1 promoted the growth and migration of non-small cell lung cancer cells by activating YAP/TEAD signaling.
Liang Z; Wang Y; Shen Z; Teng X; Li X; Li C; Wu W; Zhou Z; Wang Z
Tumour Biol; 2016 Aug; 37(8):10909-15. PubMed ID: 26886283
[TBL] [Abstract][Full Text] [Related]
10. MCM7 and its hosted miR-25, 93 and 106b cluster elicit YAP/TAZ oncogenic activity in lung cancer.
Lo Sardo F; Forcato M; Sacconi A; Capaci V; Zanconato F; Di Agostino S; Del Sal G; Pandolfi PP; Strano S; Bicciato S; Blandino G
Carcinogenesis; 2017 Jan; 38(1):64-75. PubMed ID: 27797825
[TBL] [Abstract][Full Text] [Related]
11. miR-25 Promotes Cell Proliferation, Migration, and Invasion of Non-Small-Cell Lung Cancer by Targeting the LATS2/YAP Signaling Pathway.
Wu T; Hu H; Zhang T; Jiang L; Li X; Liu S; Zheng C; Yan G; Chen W; Ning Y; Li Y; Lu Z
Oxid Med Cell Longev; 2019; 2019():9719723. PubMed ID: 31316723
[TBL] [Abstract][Full Text] [Related]
12. HNRNPK/CLCN3 axis facilitates the progression of LUAD through CAF-tumor interaction.
Li Y; Yang Y; Ma Q; Cheng H; Wang H; Ma C; Li F; Zhao S; Li X; Qi Y; Gu Z
Int J Biol Sci; 2022; 18(16):6084-6101. PubMed ID: 36439880
[No Abstract] [Full Text] [Related]
13. Inhibition of CXCR4 regulates epithelial mesenchymal transition of NSCLC via the Hippo-YAP signaling pathway.
Zheng CH; Chen XM; Zhang FB; Zhao C; Tu SS
Cell Biol Int; 2018 Sep; 42(10):1386-1394. PubMed ID: 29972256
[TBL] [Abstract][Full Text] [Related]
14. Activation of Aurora A kinase increases YAP stability via blockage of autophagy.
Wang P; Gong Y; Guo T; Li M; Fang L; Yin S; Kamran M; Liu Y; Xu J; Xu L; Peng F; Xue X; Yang M; Hung MC; Lam EW; Gu C; Wang C; Zhan Q; Liu Q
Cell Death Dis; 2019 Jun; 10(6):432. PubMed ID: 31160567
[TBL] [Abstract][Full Text] [Related]
15. COPB2 promotes cell proliferation and tumorigenesis through up-regulating YAP1 expression in lung adenocarcinoma cells.
Pu X; Wang J; Li W; Fan W; Wang L; Mao Y; Yang S; Liu S; Xu J; Lv Z; Xu L; Shu Y
Biomed Pharmacother; 2018 Jul; 103():373-380. PubMed ID: 29674272
[TBL] [Abstract][Full Text] [Related]
16. TNFAIP8 regulates Hippo pathway through interacting with LATS1 to promote cell proliferation and invasion in lung cancer.
Han Y; Tang Z; Zhao Y; Li Q; Wang E
Mol Carcinog; 2018 Feb; 57(2):159-166. PubMed ID: 28926138
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of yes-associated protein suppresses brain metastasis of human lung adenocarcinoma in a murine model.
Hsu PC; Miao J; Huang Z; Yang YL; Xu Z; You J; Dai Y; Yeh CC; Chan G; Liu S; Urisman A; Yang CT; Jablons DM; You L
J Cell Mol Med; 2018 Jun; 22(6):3073-3085. PubMed ID: 29575527
[TBL] [Abstract][Full Text] [Related]
18. A Division of Labor between YAP and TAZ in Non-Small Cell Lung Cancer.
Shreberk-Shaked M; Dassa B; Sinha S; Di Agostino S; Azuri I; Mukherjee S; Aylon Y; Blandino G; Ruppin E; Oren M
Cancer Res; 2020 Oct; 80(19):4145-4157. PubMed ID: 32816858
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-345 suppresses cell invasion and migration in non-small cell lung cancer by directly targeting YAP1.
Zhang MY; Lin J; Kui YC
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2436-2443. PubMed ID: 30964169
[TBL] [Abstract][Full Text] [Related]
20. G protein-coupled oestrogen receptor promotes cell growth of non-small cell lung cancer cells via YAP1/QKI/circNOTCH1/m6A methylated NOTCH1 signalling.
Shen Y; Li C; Zhou L; Huang JA
J Cell Mol Med; 2021 Jan; 25(1):284-296. PubMed ID: 33237585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
